84 related articles for article (PubMed ID: 8317916)
1. Sporadic amplification of the c-fms proto-oncogene in human musculoskeletal sarcomas.
Castresana JS; Barrios C; Ruiz J; Gómez L; Kreicbergs A
Anticancer Res; 1993; 13(3):807-10. PubMed ID: 8317916
[TBL] [Abstract][Full Text] [Related]
2. Amplification of the c-myc proto-oncogene in human chondrosarcoma.
Castresana JS; Barrios C; Gómez L; Kreicbergs A
Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971
[TBL] [Abstract][Full Text] [Related]
3. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
Barrios C; Castresana JS; Ruiz J; Kreicbergs A
J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
[TBL] [Abstract][Full Text] [Related]
4. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
[TBL] [Abstract][Full Text] [Related]
5. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
6. Amplification of the c-myc proto-oncogene in soft tissue sarcomas.
Barrios C; Castresana JS; Ruiz J; Kreicbergs A
Oncology; 1994; 51(1):13-7. PubMed ID: 8265096
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
8. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
Maillet MW; Robinson RA; Burgart LJ
Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
[TBL] [Abstract][Full Text] [Related]
9. SAS amplification in soft tissue sarcomas.
Smith SH; Weiss SW; Jankowski SA; Coccia MA; Meltzer PS
Cancer Res; 1992 Jul; 52(13):3746-9. PubMed ID: 1319830
[TBL] [Abstract][Full Text] [Related]
10. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.
Yang DH; Huang W; Cui J; Shu JC; Tang SH; Zhang WJ; Liang JH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):86-9. PubMed ID: 14969845
[TBL] [Abstract][Full Text] [Related]
11. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
[TBL] [Abstract][Full Text] [Related]
12. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors.
Nakayama T; Toguchida J; Wadayama B; Kanoe H; Kotoura Y; Sasaki MS
Int J Cancer; 1995 Oct; 64(5):342-6. PubMed ID: 7591308
[TBL] [Abstract][Full Text] [Related]
13. Specificity of proto-oncogene amplification in human malignant diseases.
Masuda H; Battifora H; Yokota J; Meltzer S; Cline MJ
Mol Biol Med; 1987 Aug; 4(4):213-27. PubMed ID: 3670047
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry and DNA flow cytometry in soft-tissue sarcomas.
Calonje E; Fletcher CD
Hematol Oncol Clin North Am; 1995 Jun; 9(3):657-75. PubMed ID: 7649948
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
[TBL] [Abstract][Full Text] [Related]
16. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
17. Sporadic amplification of the MYC gene in human osteosarcomas.
Ladanyi M; Park CK; Lewis R; Jhanwar SC; Healey JH; Huvos AG
Diagn Mol Pathol; 1993 Sep; 2(3):163-7. PubMed ID: 8287230
[TBL] [Abstract][Full Text] [Related]
18. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
[TBL] [Abstract][Full Text] [Related]
19. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
[TBL] [Abstract][Full Text] [Related]
20. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
